NASDAQ OMX

UK Space Agency Backs Spire's Proposal to European Space Agency as Space Mission Provider

Dela

GLASGOW, Scotland, Feb. 01, 2018 (GLOBE NEWSWIRE) -- The UK Space Agency has awarded more than £4 million to Spire Global, a satellite powered data company, to demonstrate cutting-edge space technology including 'parallel super-computing', UK Government ministers Lord Henley and Lord Duncan announced today.

Today's announcement gives the green light to missions designed to showcase the technology and put UK companies into orbit faster and at a lower cost. The UK is the largest funder of the European Space Agency's Advanced Research in Telecommunications Satellites (ARTES) programme, which transforms research into successful commercial projects.

The funding from the UK Space Agency was announced by Lord Henley, Parliamentary Under-Secretary of State at the Department for Business, Energy and Industrial Strategy, on a visit to Spire's UK base in Glasgow, where the company intends to create new jobs to add to its existing workforce.

Business Minister, the Rt. Hon. Lord Henley, said:

"Thanks to this new funding, Spire will be able to cement its activities in the UK, develop new technologies and use space data to provide new services to consumers that will allow businesses to access space quicker and at a lower cost - offering an exciting opportunity for the UK to thrive in the commercial space age.

"Through the government's Industrial Strategy, we are encouraging other high-tech British businesses to pursue more commercial opportunities with the aim of growing the UK's share of the global space market to 10% by 2030."

UK Government Minister for Scotland Lord Duncan said:

"Spire Global is at the cutting edge of technology, using satellite data to track ships, planes and weather in some of the world's most remote regions. They're also an important employer in Glasgow, investing in the area and recognising the talent of Scotland's world class engineers and scientists. We know that the space industry is important to Scotland's economy and this UK Government funding will help companies like Spire stay at the forefront of this field."

The ARTES Pioneer programme is designed to support industry by funding the demonstration of advanced technologies, systems, services and applications in a representative space environment. Part of this is to support one or more Space Mission Providers, which could provide commercial services to private companies or public bodies.

"Spire's infrastructure, capabilities, and competencies all support our submission to this program. For the launch of our 50+ satellite constellation, we quickly became our own best customer," said Theresa Condor, Spire's EVP of Corporate Development. "We're looking forward to demonstrating our end-to-end service and infrastructure on this series of validation missions. 'Space as a Service' means going from mission technical architecture to customer data/service verification, along with the ongoing development of critical enabling technologies."

One validation mission will develop parallel super-computing in space - a core component for future computationally intensive missions. A second, exploitation of Global Navigation Satellite System (GNSS) for weather applications, will leverage Galileo signals for GNSS Radio Occultation. Radio occultation is a key data input for the improvement of weather forecasts. Upon completion, the GNSS-RO technology can be immediately commercialized.

Spire Release Contact: Nick Allain, Nick@spire.com, +44-(0)744-916-8302 / +1 (628)221-5333

UK Space Agency Contact: Gareth Bethell, Gareth.bethell@ukspaceagency.bis.gsi.gov.uk, 07925 891 949




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Spire Global, Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Fentress Architects: The Future of Airports as Civic Spaces21.5.2018 22:27Pressmeddelande

The European Cultural Centre and Global Art Affairs Foundation invited Fentress Architects and North Carolina State University College of Design to participate in the 2018 Venice Architecture Biennale May 26-November 25, 2018, at the historic Palazzo Bembo. Denver, Colo. - May 21, 2018, May 21, 2018 (GLOBE NEWSWIRE) -- Architecture students from North Carolina State University College of Design will join Fentress at the Palazzo Bembo to present their designs for airports of the future. Fentress has been guiding students in preparation for the exhibition, which allows 11 students to embark on a once-in-a-lifetime opportunity to travel to Italy for the 2018 Venice Biennale of Architecture. Their designs will be featured in the "Time Space Existence" exhibit, offering the public a glimpse at the future of airport design. The students are participating in an Airport Design course with Principal in Charge of Design Curt Fentress, FAIA, RIBA, and Alumni Distinguished Professor of Architectur

Oxford Immunotec's T-SPOT®.TB Test Included in the World Health Organization's First-Ever Essential Diagnostics List21.5.2018 22:15Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 21, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that the Company's T-SPOT.TB test for tuberculosis (TB) infection has been included in the World Health Organization (WHO) Model List of Essential In Vitro Diagnostics (EDL) - First Edition. The EDL includes the 113 most important tests recommended by WHO for use at various levels of the health care system. These essential diagnostics satisfy the priority health care needs of the population and were selected with due regard to disease prevalence and public health relevance, evidence of efficacy and accuracy, and comparative cost-effectiveness. 58 of the tests listed are for the detection and diagnosis of a wide range of common conditions, providing an essential package that can form the basis for screening and management of patients. The remaining 55 tests are designed for the detection, diagnosis, and moni

Virgin Pulse and RedBrick Health Joining Forces to Create World's Largest Digital Employee Wellbeing and Engagement Company21.5.2018 17:00Pressmeddelande

Merger Will Create First and Only One-Stop-Shop for Employee Health, Wellbeing and Benefits Engagement; Combined Company Will Have More Than 3,300 Customers Across 190 Countries PROVIDENCE, R.I., May 21, 2018 (GLOBE NEWSWIRE) -- Providence-based Virgin Pulse and Minneapolis-based RedBrick Health announced today that the industry pioneers will merge, creating the world's largest, most comprehensive digital health and engagement company. This powerful combination will deliver the industry's only fully integrated digital platform, with benefits navigation and live coaching to support global clients and members across the entire health, wellbeing and benefits lifecycle - from screening and assessment to activation, behavior change and the adoption of sustainable, healthy habits. "We are thrilled to join with RedBrick to set a new vision and standard for employee health, wellbeing and engagement," said David Osborne, Virgin Pulse CEO, who will serve as CEO of the combined company. "Bringing

Hotels.com App Wins 2018 MediaPost Appy Award in Travel & Tourism Category21.5.2018 16:00Pressmeddelande

Developed by EPAM, app is recognized for creativity and excellence in app design NEWTOWN, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Hotels.com® and EPAM Systems, Inc. (NYSE:EPAM) announced their triumphant win at the 2018 MediaPost Appy Awards in the Travel and Tourism category this week. The Hotels.com mobile app, developed in collaboration with EPAM Systems, Inc., a leading global provider of digital platform engineering and software development services, has been crowned the best app developed for airlines, hotels, travel search engines, destinations, cruises, travel advice or car rentals. With over 70 million downloads and a 4.5+ star rating from consumers on both iOS and Android app stores, the Hotels.com app has now been recognized by the industry leading Appy Awards, which honor creativity and excellence in app design. The app provides a simple, fast and secure way for users to plan, book and manage hotel reservations, and allows travelers to book hundreds of thousands of places to

Karolinska Development's portfolio company Pharmanest appoints new CEO21.5.2018 15:01Pressmeddelande

STOCKHOLM, May 21, 2018. Karolinska Development's portfolio company Pharmanest AB announces the appointment of Helena Jansson as new Chief Executive Officer. Helena is an experienced life science executive, with a proven track record of successful business development and commercialization of pharmaceutical products. She replaces Gunilla Lundmark, who leaves her position after seven years. Helena Jansson has long experience in the life science industry and a broad knowledge base with a focus on business development and commercialization of pharmaceutical portfolios. She has spent a substantial part of her career at Medivir AB, in positions such as Business Unit Director, Head of Supply Chain and Director Alliance Management. In 2017, Pharmanest signed an outlicensing agreement with Gedeon Richter, a leading European pharmaceutical company within women's health. The agreement gives Gedeon Richter the marketing and sales rights to commercialize Pharmanest's first product SHACT (Short Act

Karolinska Development's portfolio company Pharmanest appoints new CEO21.5.2018 15:01Pressmeddelande

STOCKHOLM, May 21, 2018. Karolinska Development's portfolio company Pharmanest AB announces the appointment of Helena Jansson as new Chief Executive Officer. Helena is an experienced life science executive, with a proven track record of successful business development and commercialization of pharmaceutical products. She replaces Gunilla Lundmark, who leaves her position after seven years. Helena Jansson has long experience in the life science industry and a broad knowledge base with a focus on business development and commercialization of pharmaceutical portfolios. She has spent a substantial part of her career at Medivir AB, in positions such as Business Unit Director, Head of Supply Chain and Director Alliance Management. In 2017, Pharmanest signed an outlicensing agreement with Gedeon Richter, a leading European pharmaceutical company within women's health. The agreement gives Gedeon Richter the marketing and sales rights to commercialize Pharmanest's first product SHACT (Short Act

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum